Please login to the form below
Ranbaxy wins FDA approval for Metformin in US
India-based Ranbaxy Laboratories' 100 per cent-owned Ohm Laboratories has won FDA approval to manufacture and market Metformin tablets in the US.
India-based Ranbaxy Laboratories' 100 per cent-owned Ohm Laboratories has won FDA approval to manufacture and market Metformin tablets in the US.
Ipca Laboratories, which has a strategic alliance with Ranbaxy, will manufacture the formulation at its facilities in India. Ranbaxy will commercialise the product in the US market, Ipca revealed in a press statement to the Bombay Stock Exchange.
Total annual US sales for Metformin, an insulin sensitising agent, was USD 379m, according to Ranbaxy.
Share
Related Hub content
Featured jobs
-
Associate Medical Director
-
Salary TBC
-
Scientific Director
-
Highly Competitive Salary &Benefits
-
Associate Medical Director
-
Highly Competitive
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Scientific Team Lead
-
Competitive Salary
- Experienced Editor, London, Medical Communications
-
Competitive package
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Senior Systematic Review Analyst - Oxford
-
Negotiable
- Director Healthcare PR Communications
-
Salary TBC
- Account Manager, Healthcare Advertising
-
Salary TBC
- Account Director – Global Healthcare PR
-
Salary TBC
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
-
Account Director - Digital
-
Great salary and benefits
Subscribe to our email news alerts
- Encouraging data for GenSight’s blinding retinal disease gene therapy
- Lonely planet: why there is dwindling value in pharma travelling alone
- AZ and Clovis PARP inhibitors show their mettle at ESMO
- AZ and Medicines Catapult collaborate on innovative sound tech in drug discovery
- Dynavax is ‘deal-ready’ after solid ESMO data; analyst
- Artificial intelligence in healthcare
PMHub
Hayward Medical Communications
Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...
Latest intelligence
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe's leading hub for life sciences innovation...
Quick links
Infographics
